Detalles de la búsqueda
1.
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis.
Ann Rheum Dis
; 83(1): 88-95, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657927
2.
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Lancet
; 399(10320): 161-171, 2022 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861168
3.
The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysis.
Clin Exp Rheumatol
; 41(12): 2484-2492, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38149516
4.
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome.
Ann Rheum Dis
; 81(7): 979-989, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35393271
5.
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Proc Natl Acad Sci U S A
; 116(27): 13490-13497, 2019 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31213547
6.
Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate?
Rheumatology (Oxford)
; 60(8): 3528-3539, 2021 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31236580
7.
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
Rheumatology (Oxford)
; 60(3): 1364-1375, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32949140
8.
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndrome.
Clin Exp Rheumatol
; 39 Suppl 133(6): 100-106, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796851
9.
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
Ann Rheum Dis
; 79(12): 1588-1599, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32963045
10.
Mediterranean diet and risk of Sjögren's syndrome.
Clin Exp Rheumatol
; 38 Suppl 126(4): 216-221, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095150
11.
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.
Hum Mol Genet
; 26(13): 2565-2576, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28379387
12.
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Ann Rheum Dis
; 78(2): 249-260, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30472652
13.
B cell depletion with rituximab in the treatment of primary Sjögren's syndrome: what have we learnt?
Clin Exp Rheumatol
; 37 Suppl 118(3): 217-224, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464681
14.
Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
Rheumatol Int
; 39(11): 1867-1873, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31250166
15.
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply.
Lancet
; 400(10355): 808-809, 2022 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36088946
16.
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
Ann Rheum Dis
; 77(3): 412-416, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29275334
17.
Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
J Autoimmun
; 94: 143-155, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30119881
18.
B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.
Rheumatology (Oxford)
; 57(7): 1222-1227, 2018 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608774
19.
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
Rheumatology (Oxford)
; 57(5): 921-930, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474655
20.
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
Ann Rheum Dis
; 76(1): 9-16, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27789466